MTOR and neoplasm: The mTOR inhibitors include everolimus and temsirolimus, which mainly inhibit the proliferation and division of tumor cells and promote their apoptosis by interfering with signal transduction pathways.[48] These drugs have been approved by the FDA and have shown good results in clinical trials.